-transparent.png){kind=logo}
Two oral 0.5-g doses of probenecid given 7 and 1 h before a single 1-g intramuscular dose of cefamandole resulted in higher serum levels of cefamandole than when cefamandole was given alone: 37 versus 20 mug per ml of serum, respectively. Cefamandole was not measurable (<0.3 mug/ml) at 8 h when it was given alone, whereas an average 8-h value of 2.9 mug/ml was obtained after pretreatment with probenecid. By prolonging the duration of these high cefamandole levels, probenecid should permit the treatment of more serious clinical infections, including those due to relatively resistant organisms, or permit a reduction in either the dosage of cefamandole or the frequency of administration.
R S Griffith, and
H R Black, and
G L Brier, and
J D Wolny
August 1965,
The American journal of the medical sciences,
R S Griffith, and
H R Black, and
G L Brier, and
J D Wolny
March 1979,
Antimicrobial agents and chemotherapy,
R S Griffith, and
H R Black, and
G L Brier, and
J D Wolny
July 1996,
Japanese journal of pharmacology,
R S Griffith, and
H R Black, and
G L Brier, and
J D Wolny
July 1983,
Annals of clinical biochemistry,
R S Griffith, and
H R Black, and
G L Brier, and
J D Wolny
January 1972,
Patologia polska,
R S Griffith, and
H R Black, and
G L Brier, and
J D Wolny
April 1990,
Prostaglandins, leukotrienes, and essential fatty acids,
R S Griffith, and
H R Black, and
G L Brier, and
J D Wolny
October 1953,
Revista medica de Chile,
R S Griffith, and
H R Black, and
G L Brier, and
J D Wolny
March 1955,
Journal of applied physiology,
R S Griffith, and
H R Black, and
G L Brier, and
J D Wolny
June 1975,
Journal of animal science,
R S Griffith, and
H R Black, and
G L Brier, and
J D Wolny
November 1977,
The American journal of medicine,
